F-VASI75

Advertisement

cGxPJobs Banner

Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo

NEW YORK, July 30, 2026 Pfizer Inc. announced positive topline Phase 3 results for LITFULO™ (ritlecitinib) in patients with...

By cGxPwire Editor
July 31, 2026

Read More

Advertisement

cGxPJobs

Directory